Evotec and Galapagos enter into collaboration in the field of fibrosis
Belgian biotech group Galapagos said its experimental drug to treat bowel disease ulcerative colitis had failed to prove its efficacy in a medical trial and it would discontinue the program for that disease.
Market Place
Share